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In this issue of Immunity, Lee et al. (2010) demonstrate that the mammalian Target of Rapamycin Complex 2
promotes the differentiation of T helper 1 (Th1) cells via the kinase Akt, whereas it independently fosters Th2
cell generation via another kinase, PKC-q.Regulation of the manifold and flexible
requirements of an efficient immune
response to eliminate dangerous micro-
bes depends on a delicate balance of
diverse T helper (Th) cell subsets (Zhu
et al., 2010). Hence, naive CD4+ Th cells
differentiate into polarized effector Th
cell subsets depending on the priming
cytokine milieu. Th1 cells can be gener-
ated by exposure to cytokines like IL-12
and IFN-g to defend viruses and intracel-
lular bacteria, whereas IL-4, IL-5, and IL-
13 induce Th2 cells to promote B cell-
mediated immunity and defend parasitic
infections. The minimal cytokine cocktail
IL-6 plus TGF-b enables the development
of IL-17 producing Th17 cells that are
associated with protection against extra-
cellular bacteria as well as autoimmunity.
Alternatively, naive CD4+ T cells may
differentiate into induced regulatory T
(iTreg) cells after stimulation with TGF-b
and IL-2 that are vital for the induction
and maintenance of peripheral tolerance.
Although the respective cytokine milieu
and the transcription factors that control
Th cell differentiation have been charac-
terized in considerable detail, the intracel-
lular pathways that dictate the balance
between the individual effector lineages
are still incompletely understood. In this
issue of Immunity, Lee et al. (2010)
demonstrate that mTORC2 is centrally
positioned as a Th cell signaling diversifier
to specifically induce the subsequent
differentiation of Th1 and Th2 cells via
the two kinases Akt and PKC-q, respec-
tively.
mTOR is a signaling kinase that affects
broad aspects of cellular functions
including immunity, metabolism, growth,
survival, and aging (Weichhart and Sae-
mann, 2009). In the immune system,mTOR is a critical regulator of memory
CD8+ T cell generation as well as inflam-
matory responses in myeloid antigen-pre-
senting cells (Araki et al., 2009; Weichhart
et al., 2008). mTOR is the core component
of mTORC1 (mTOR complex 1), which is
composed by the adaptor protein Raptor,
whereas Rictor and Sin1 classify
mTORC2. mTORC1 and mTORC2 are
a coupled part of a complex signaling
pathway that integrates various environ-
mental cues including growth factors,
cytokines, and nutrients. mTORC2 phos-
phorylates the kinase Akt on serine 473,
whereas the PI3-kinase induces Akt
phosphorylation at threonine 308 to direct
mTORC1 activation via Rheb, a RAS-like
GTPase. Rapamycin, the prototypical
inhibitor of mTORC1, has been tradition-
ally employed to study the impact of
mTOR on the development, activation,
and proliferation of Th cells. Recently,
mTOR-deficient Th cells have been
shown that are unable to differentiate
into Th1, Th2, and Th17 cells, but prefer-
entially develop into iTreg cells (Delgoffe
et al., 2009). Because mTOR deficiency
wipes out both mTORC1 and mTORC2,
it is unclear so far which mTOR complex
is critical for Th cell lineage commitment.
Lee et al. (2010) now directly addressed
this important question by describing the
generation of mice that selectively lack
the essential mTORC2 subunit Rictor in
T cells via the cre-lox system. Deleting
Rictor by this approach in thymocytes
after the double-positive thymocyte stage
did not impede general CD4+ T cell devel-
opment and also did not influence the
generation of natural Treg cells. Analyzing
the activity of mTORC1 and mTORC2 in
Rictor-deficient mature CD4+ T cells,
mTORC2-dependent phosphorylation ofImmunityAkt S473 was defective after stimulation
with CD3 and CD28 mAb, whereas
mTORC1-mediated phosphorylation of
S6K1 was intact. Functionally, however,
it was found that Rictor-deficient CD4+
T cells were unable to differentiate into
both Th1 or Th2 cells in vitro, demon-
strating that mTORC2 is vital for Th1 and
Th2 cell differentiation. The lineage-deter-
mining transcription factors for Th1 and
Th2 development, T-bet and GATA3,
respectively, were also reduced in the
absence of Rictor. These data were
confirmed indirectly by measuring Th
cell-mediated antibody responses in their
mice in vivo; Th1 and Th2 cell-dependent
antibody production (IgG2a, IgG3 and
IgG1, IgE, respectively) was markedly
reduced after the appropriate immuniza-
tion. In contrast, Th17 cell differentiation
was not compromised in Rictor-deficient
cells in vitro, indicating that mTORC1
promotes Th17 cell differentiation,
whereas mTORC2 critically determines
Th1 and Th2 cell lineage commitment.
However, caution is warranted from
a straightforward interpretation, because
in their current study Lee et al. (2010)
induced Th17 cell differentiation by exog-
enous TGF-b, IL-6, and IL-23, whereas in
the previous study only TGF-b and IL-6
were used (Delgoffe et al., 2009). Hence,
mTORC2 might be still important for
Th17 cell differentiation under conditions
without the help of IL-23.
As outlined, mTOR-deficient CD4+
T cells preferentially differentiate into an
iTreg cell phenotype during nonpolarizing
and Th1 cell-polarizing conditions in vitro
and in vivo, whereas Rheb-deficient
T cells corresponding to cells with
mTORC1 absence did not recapitulate
these effects, implying that mTORC232, June 25, 2010 ª2010 Elsevier Inc. 727
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Figure 1. Th1 and Th2 Cell Differentiation
Is Controlled bymTORC2 via Akt and PKC-q,
Respectively
mTOR is contained in two protein complexes in the
CD4+ T cell, mTORC1 and mTORC2, both of which
are activated after CD3 and CD28 engagement.
mTORC2 directly phosphorylates the protein
kinase Akt to induce expression of the Th1 cell-
determining transcription factor T-bet and hence
Th1 cell differentiation. mTORC2 also activates
PKC-q to upregulate the expression of GATA-3,
the central Th2 cell-determining transcription
factor in CD4+ T cells. However, a role of mTORC1
in Th1 and Th2 cell generation cannot be excluded
so far. In addition, mTORC1 and mTORC2 nega-
tively regulate iTreg cell development under certain
conditions, whereas mTORC1 seems to be exclu-
sively dominant for Th17 cell differentiation.
Some unidentified factors and/or the initial
signaling strength might mediate a differential acti-
vation signal to mTORC1 versus mTORC2 influ-
encing effector Th cell differentiation.
Immunity
Previewsmight prevent iTreg cell conversion (Del-
goffe et al., 2009). In seeming contrast,
Lee et al. (2010) showed that mTORC2
deficiency induced by loss of Rictor did
enhance iTreg cell generation as
measured by the expression of FoxP3
under neutral conditions in the presence
of TGF-b but not without TGF-b or under
Th1 and Th2 cell-driving conditions.
Although the experimental setup of Del-
goffe et al. (2009) and Lee et al. (2010)
are not directly comparable, one possible
explanation might be that both mTORC1
and mTORC2 are essential for controlling
iTreg cell expansion. This view is sup-
ported by the present study showing728 Immunity 32, June 25, 2010 ª2010 Elsevthat rapamycin can further enhance
FoxP3 expression even in Rictor-deficient
CD4+ T cells. Alternatively, Rictor or Rheb
might influence iTreg cell generation also
in an mTORC2- or mTORC1-independent
manner, respectively.
How does mTORC2 promote both Th1
and Th2 cell differentiation and prolifera-
tion? Previous studies with rapamycin
suggested that mTORC1 is vital for effi-
cient cell cycle progression of CD4+
T cells by blocking G1-S transition (Song
et al., 2007). In the current study, Lee
et al. (2010) found that Rictor-deficient
CD4+ T cells proliferated poorly in
response to CD3 and CD28, because of
a block at the G1-S phase. Hence, either
both mTORC1 and mTORC2 are impor-
tant for efficient cell cycle progression,
or the well-known defect in cell-cycle
progression upon treatment with rapamy-
cin is attributable to a rapamycin-sensi-
tive mTORC2 activity. Indeed, Lee et al.
(2010) showed that rapamycin also
affected mTORC2 activity in CD4+ T cells,
a phenomenon that has also been recog-
nized in other cell types.
The most intriguing set of data of the
current study is the finding that mTORC2
splits its function to promote both Th1
and Th2 cell differentiation to distinct
protein kinases. Because Akt is the best-
characterized kinase downstream of
mTORC2, the authors reconstituted Ric-
tor-deficient CD4+ T cells with a constitu-
tively active Akt mutant and monitored the
Th1 and Th2 cell differentiation potential:
the Akt mutant rescued the Th1 cell differ-
entiation defect, but it was ineffective in
restoring Th2 cell differentiation. In agree-
ment, active Akt specifically rescued
expression of the transcription factor T-
bet but not GATA3. Phosphorylation of
the negative regulator FoxO1 by Akt
inhibits its activity and thereby enhances
T cell proliferation as well as T-bet expres-
sion. Indeed, Rictor-deficient CD4+ T cells
showed reduced phosphorylation of
FoxO1 compared to WT cells. Because
all three Akt isoforms are expressed in
ab T lymphocytes, it is unclear which iso-
form is critical downstream of mTORC2
for Th1 cell generation. Nevertheless,
these data perfectly fit in a model where
Akt acts as an amplifier of Th1 cell differ-
entiation (Arimura et al., 2004). Recently,
mTORC2 has been implicated in acti-
vating several PKC kinases (Ikenoue
et al., 2008) and because PKC-q is essen-ier Inc.tial for Th2 cell priming (Marsland and
Kopf, 2008), Lee et al. (2010) investigated
whether PKC-q might be involved in
mTORC2-dependent Th cell differentia-
tion. Reconstitution of Rictor-deficient
T cells with constitutive active PKC-q
specifically reverted the Th2 but not the
Th1 cell defect. Along these lines, the
mutant PKC-q reestablished GATA3
expression during Th2 cell differentiation,
but did not influence T-bet under Th1 cell-
priming conditions. Moreover, because
the important transcription factor NF-kB
has been shown to be activated by
PKC-q to drive Th2 cell differentiation,
the effects of Rictor deficiency on NF-kB
were analyzed. It was shown that CD3-
and CD28-induced NF-kB activity was
strongly diminished in Rictor-deficient
CD4+ T cells, but could be rescued by
overexpression of the PKC-q mutant.
These results suggest that mTORC2
promotes Th1 cell differentiation via Akt,
whereas mTORC2 drives the generation
of Th2 cells via PKC-q (Figure 1).
A major discrepancy between the
present results and previous data with
mTOR-deficient CD4+ T cells resides in
the conclusion about the critical involve-
mentof STATs that mediate the expression
of the lineage-specific transcription factors
for Th cell differentiation. Whereas mTOR-
deficient cells display a decrease in STAT4
and STAT3 activation, Rictor-deficient
T cells showed completely unimpaired
STAT activation. Moreover, rapamycin
failed to block STAT4 and STAT3 phos-
phorylation in the experiments of Lee
et al. (2010). There remains the possibility
that rapamycin might not completely block
mTORC1 signaling. Alternatively, different
experimental setups, e.g., primary cellular
activation versus preactivated cells, might
explain this inconsistency.
Interestingly, the Th cell-priming condi-
tions only modestly influence the CD3-
and CD28-induced phosphorylation of
S6K1, Akt S473, and PKC-q, e.g., the rela-
tive activation of mTORC1 versus
mTORC2 and of Akt versus PKC-q after
4 days of differentiation, indicating that
the mTOR pathway might be an intrinsic
regulator of Th cell differentiation inde-
pendent of environmental cues (e.g., IL-
12 or IL-4) that would favor Th1 or Th2
cell generation, respectively. However,
various alternative scenarios are conceiv-
able: the time point to assess mTOR acti-
vation might have been too late or the
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cient to influence Th cell differentiation
via altered mTORC1-mTORC2 and Akt-
PKC-q activation. Moreover, the strength
of the CD3 and CD28 signal might be
important for selective mTOR pathway
activation or other environmental factors
influence the Th cell differentiation
process via mTOR signaling. Finally, as
nutrients such as amino acids or glucose
directly control the activation of the
mTOR pathway, it is tempting to hypothe-
size that nutrients do not merely control
T cell proliferation but that the nutritional
status might also control Th cell differenti-
ation via the mTOR signaling complex.REFERENCES
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Whether apoptosis is relevant for interclonal competition of T cells after antigen encounter has remained
uncertain. In this issue of Immunity, Wensveen et al. (2010) establish a critical role for the proapoptotic
BH3-only protein Noxa in this selection process.Apoptosis plays a critical role in the selec-
tion of functionally competent immune
cells. During lymphocyte development,
apoptosis eliminates cells that lack antigen
receptor expression in a process known as
‘‘death by neglect,’’ but also mediates the
death of cells that express potentially
autoreactive antigen receptors during
‘‘negative selection,’’ critical for generating
tolerance. Both types of cell death are
controlled by B cell lymphoma-2 (Bcl-2)
family proteins that fall into pro- and antia-
poptotic groups and that integrate different
forms of cell stress as well as develop-
mental cues at the level of mitochondria in
order to preserve cell survival or initiate
cell death (Strasser, 2005). Apoptosis has
also been recognized as critical for affinity
maturationofBcellscompeting fora limited
amount of antigen and supporting cyto-
kines in germinal center reactions. This
process secures that only clones ex-
pressing B cell receptors with the highest
affinity are able to thrive. Bcl2l11, alsoknown as Bcl-2 interacting mediator of
cell death (Bim), a BH3-only protein
belonging to one proapoptotic subclass
of the Bcl-2 family with at least eight
members, has been shown to be critical
for this selection process (Fischer et al.,
2007). Bim is also critical for T cell deletion
after antigen clearance in which other BH3-
only proteins, such as Puma or Noxa (also
known as Pmaip1), can play auxiliary roles
(Bauer et al., 2006). Notably, the latter two
proteins have been identified as direct
target genes of the tumor suppressor p53,
activated in order to execute apoptosis
induced by DNA damage. However, the
physiological role of Noxa has remained
rather obscure, given that its loss confers
only mild resistance to DNA-damage-
induced apoptosis, and only in selected
cell types (Ploner et al., 2008).
One of the first hints that Noxa can
act outside the DNA-damage response
came from the demonstration that its
expression was induced in response toTCR ligation in human naive T cells and
that repression of protein expression by
RNA interference provided a selective
advantage in cell-growth competition
experiments to Jurkat T acute lympho-
blastic leukemia and primary activated
T cells under conditions of glucose limita-
tion (Alves et al., 2006). Others observed
that Noxa limits the lifespan of memory
T cells (Yamashita et al., 2008) or, together
with Bim, restricts survival of NK cells
in the absence of their major survival
cytokine, IL-15 (Huntington et al., 2007).
Performing a consequent follow up of
their initial observations, Wensveen et al.
(2010) now provide compelling evidence
that Noxa limits the survival of T cell clones
that express low-affinity TCRs during
interclonal competition, a process that
leads to the outgrowth of the ‘‘best-fit’’
high-avidity Tcell clones froma largepanel
of antigen-reactive naive T cells during
antigenic challenge (Malherbe et al., 2004;
Zehn et al., 2009).32, June 25, 2010 ª2010 Elsevier Inc. 729
